Novel therapeutic approaches for corneal disease

Discovery Medicine

Volumn 15, Issue 84, 2013, Pages 291-299

  Williams, Keryn A ^a   Irani, Yazad D ^a   Klebe, Sonja ^a  

^a FLINDERS UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

BIOMATERIAL; VASCULOTROPIN A;

ARTIFICIAL ORGAN; CORNEA DISEASE; DRUG ANTAGONISM; DRUG DELIVERY SYSTEM; GENE THERAPY; HUMAN; REVIEW; STEM CELL NICHE; TISSUE ENGINEERING;

ARTIFICIAL ORGANS; BIOCOMPATIBLE MATERIALS; CORNEAL DISEASES; DRUG DELIVERY SYSTEMS; GENETIC THERAPY; HUMANS; STEM CELL NICHE; TISSUE ENGINEERING; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84886296037     PISSN: 15396509     EISSN: 19447930     Source Type: Journal    
DOI: None     Document Type: Article

References (84)

1. Aburahma MH, Mahmoud AA. Biodegradable ocular inserts for sustained delivery of brimonidine tartarate: preparation and in vitro/in vivo evaluation. AAPS PharmSciTech 12(4):1335-1347, 2011.
2. Allansmith M, de Ramus A, Maurice D. The dynamics of IgG in the cornea. Invest Ophthalmol Vis Sci 18:947-955, 1979.
3. Allen EH, Atkinson SD, Liao H, Moore JE, Leslie Pedrioli DM, Smith FJ, Mclean WH, Moore CB. Allele-specific siRNA silencing for the common keratin 12 founder mutation in Meesmann epithelial corneal dystrophy. Invest Ophthalmol Vis Sci 54(1):494-502, 2013.
4. Ambati BK, Nozaki M, Singh N, Takeda A, Jani PD, Suthar T, Albuquerque RJ, Richter E, Sakurai E, Newcomb MT, Kleinman ME, Caldwell RB, Lin Q, Ogura Y, Orecchia A, Samuelson DA, Agnew DW, St Leger J, Green WR, Mahasreshti PJ, et al. Corneal avascularity is due to soluble VEGF receptor-1. Nature 443(7114):993-997, 2006.
5. Anshu A, Price MO, Price FW Jr. Risk of corneal transplant rejection significantly reduced with Descemet's membrane endothelial keratoplasty. Ophthalmology 119(3):536-540, 2012.
6. Baharvand H, Heidari M, Ebrahimi M, Valadbeigi T, Salekdeh GH. Proteomic analysis of epithelium-denuded human amniotic membrane as a limbal stem cell niche. Mol Vis 13:1711-1721, 2007.
7. Bakhshandeh H, Soleimani M, Hosseini SS, Hashemi H, Shabani I, Shafiee A, Nejad AH, Erfan M, Dinarvand R, Atyabi F. Poly (epsilon-caprolactone) nanofibrous ring surrounding a polyvinyl alcohol hydrogel for the development of a biocompatible two-part artificial cornea. Int J Nanomedicine 6:1509-1515, 2011.
8. Baradaran-Rafii A, Eslani M, Djalillian AR. Complications of keratolimbal allograft surgery. Cornea 32(5):561-566, 2013.
9. Baylis O, Rooney P, Figueiredo F, Lako M, Ahmad S. An investigation of donor and culture parameters which influence epithelial outgrowths from cultured human cadaveric limbal explants. J Cell Physiol 228(5):1025-1030, 2013.
10. Bentley E, Murphy CJ, Li F, Carlsson DJ, Griffith M. Biosynthetic corneal substitute implantation in dogs. Cornea 29(8):910-916, 2010.
11. Bray LJ, George KA, Ainscough SL, Hutmacher DW, Chirila TV, Harkin DG. Human corneal epithelial equivalents constructed on Bombyx mori silk fibroin membranes. Biomaterials 32(22):5086-5091, 2011.
12. Brereton HM, Taylor SD, Farrall A, Hocking D, Thiel MA, Tea M, Coster DJ, Williams KA. Influence of format on in vitro penetration of antibody fragments through porcine cornea. Br J Ophthalmol 89(9):1205-9120, 2005.
13. Chang JH, Gabison EE, Kato T, Azar DT. Corneal vascularization. Curr Opin Ophthalmol 12:242-249, 2001.
14. Chang JH, Garg NK, Lunde E, Han KY, Jain S, Azar DT. Corneal neovascularization: an anti-VEGF therapy review. Surv Ophthalmol 57(5):415-429, 2012.
15. Chien Y, Liao YW, Liu DM, Lin HL, Chen SJ, Chen HL, Peng CH, Liang CM, Mou CY, Chiou SH. Corneal repair by human corneal keratocyte-reprogrammed iPSCs and amphiphatic carboxymethyl-hexanoyl chitosan hydrogel. Biomaterials 33(32):8003-8016, 2012.
16. Colby KA, Koo EB. Expanding indications for the Boston keratoprosthesis. Curr Opin Ophthalmol 22(4):267-273, 2011.
17. Contreras-Ruiz L, De La Fuente M, Garcia-Vazquez C, Saez V, Seijo B, Alonso MJ, Calonge M, Diebold Y. Ocular tolerance to a topical formulation of hyaluronic acid and chitosan-based nanoparticles. Cornea 29(5):550-558, 2010.
18. Coster DJ, Williams KA. The impact of corneal allograft rejection on the long-term outcome of corneal transplantation. Am J Ophthalmol 140(6):1112-1122, 2005.
19. Di Girolamo N, Bosch M, Zamora K, Coroneo MT, Wakefield D, Watson SL. A contact lens-based technique for expansion and transplantation of autologous epithelial progenitors for ocular surface reconstruction. Transplantation 87(10):1571-1578, 2009.
20. Dietrich-Ntoukas T, Hofmann-Rummelt C, Kruse FE, Schlötzer-Schrehardt U. Comparative analysis of the basement membrane composition of the human limbus epithelium and amniotic membrane epithelium. Cornea 31(5):564-569, 2012.
21. DiVito MD, Rudisill SG, Stein A, Patel SV, McLaren JW, Hubel A. Silica hybrid for corneal replacement: optical, biomechanical, and ex vivo biocompatibility studies. Invest Ophthalmol Vis Sci 53(13):8192-8199, 2012.
22. Dua HS, Shanmuganathan VA, Powell-Richards AO, Tighe PJ, Joseph A. Limbal epithelial crypts: a novel anatomical structure and a putative limbal stem cell niche. Br J Ophthalmol 89(5):529-532, 2005.
23. Echevarria TJ, Chow S, Watson S, Wakefield D, Di Girolamo N. Vitronectin: a matrix support factor for human limbal epithelial progenitor cells. Invest Ophthalmol Vis Sci 52(11):8138-8147, 2011.
24. Elbadawy HM, Gailledrat M, Desseaux C, Ponzin D, Ferrari S. Targeting herpetic keratitis by gene therapy. J Ophthalmol, epub ahead of print, Dec. 26, 2012.
25. Elsaid N, Jackson TL, Gunic M, Somavarapu S. Positively charged amphiphilic chitosan derivative for the transscleral delivery of rapamycin. Invest Ophthalmol Vis Sci 53(13):8105-8111, 2012.
26. Ferrari G, Bignami F, Giacomini C, Franchini S, Rama P. Safety and efficacy of topical infliximab in a mouse model of ocular surface scarring. Invest Ophthalmol Vis Sci 54(3):1680-1688, 2013.
27. Garty S, Shirakawa R, Warsen A, Anderson EM, Noble ML, Bryers JD, Ratner BD, Shen TT. Sustained antibiotic release from an intraocular lens-hydrogel assembly for cataract surgery. Invest Ophthalmol Vis Sci 52(9):6109-6116, 2011.
28. George AJ, Larkin DF. Corneal transplantation: the forgotten graft. Am J Transplant 4(5):678-685, 2004.
29. Gulsen D, Chauhan A. Dispersion of microemulsion drops in HEMA hydrogel: a potential ophthalmic drug delivery vehicle. Int J Pharm 292(1-2):95-117, 2005.
30. Gulsen D, Li CC, Chauhan A. Dispersion of DMPC liposomes in contact lenses for ophthalmic drug delivery. Curr Eye Res 30(12):1071-1080, 2005.
31. Hao J, Li SK, Liu CY, Kao WW. Electrically assisted delivery of macromolecules into the corneal epithelium. Exp Eye Res 89(6):934-941, 2009.
32. Hayashi R, Ishikawa Y, Ito M, Kageyama T, Takashiba K, Fujioka T, Tsujikawa M, Miyoshi H, Yamato M, Nakamura Y, Nishida K. Generation of corneal epithelial cells from induced pluripotent stem cells derived from human dermal fibroblast and corneal limbal epithelium. PLoS One 7(9):e45435, 2012.
33. Ionescu AM, Alaminos M, de la Cruz Cardona J, de Dios García-López Durán J, González-Andrades M, Ghinea R, Campos A, Hita E, del Mar Pérez M. Investigating a novel nanostructured fibrin-agarose biomaterial for human cornea tissue engineering: rheological properties. J Mech Behav Biomed Mater 4(8):1963-7193, 2011.
34. Jain D, Carvalho E, Banerjee R. Biodegradable hybrid polymeric membranes for ocular drug delivery. Acta Biomater 6(4):1370-1379, 2010.
35. Jenkins C, Tuft S, Liu C, Buckley R. Limbal transplantation in the management of chronic contact-lens-associated epitheliopathy. Eye (Lond) 7(5):629-633, 1993.
36. Kashanian S, Harding F, Irani Y, Klebe S, Marshall K, Loni A, Canham L, Fan D, Williams KA, Voelcker NH, Coffer JL. Evaluation of mesoporous silicon/polycaprolactone composites as ophthalmic implants. Acta Biomater 6(9):3566-3572, 2010.
37. Kaur IP, Rana C, Singh M, Bhushan S, Singh H, Kakkar S. Development and evaluation of novel surfactant-based elastic vesicular system for ocular delivery of fluconazole. J Ocul Pharmacol Ther 28(5):484-496, 2012.
38. Kim LA, D'Amore PA. A brief history of anti-VEGF for the treatment of ocular angiogenesis. Am J Pathol 181(2):376-379, 2012.
39. Kinoshita S, Kiorpes TC, Friend J, Thoft RA. Limbal epithelium in ocular surface wound healing. Invest Ophthalmol Vis Sci 23:73-80, 1982.
40. Klebe S, Sykes PJ, Coster DJ, Bloom DC, Williams KA. Gene transfer to ovine corneal endothelium. Clin Experiment Ophthalmol 29(5):316-322, 2001.
41. Lai CM, Spilsbury K, Brankov M, Zaknich T, Rakoczy PE. Inhibition of corneal neovascularization by recombinant adenovirus mediated antisense VEGF RNA. Exp Eye Res 75(6):625-634, 2002.
42. Larson T, Nussenblatt RB, Sen HN. Emerging drugs for uveitis. Expert Opin Emerg Drugs 16(2):309-22, 2011.
43. Law SL, Huang KJ, Chiang CH. Acyclovir-containing liposomes for potential ocular delivery. Corneal penetration and absorption. J Control Release 63(1-2):135-140, 2000.
44. Leszczynski R, Stodolak E, Wieczorek J, Orlowska-Heitzman J, Gumula T, Blazewicz S. In vivo biocompatibility assessment of (PTFE-PVDF-PP) terpolymer-based membrane with potential application for glaucoma treatment. J Mater Sci Mater Med 21(10):2843-2851, 2010.
45. Li N, Zhuang CY, Wang M, Sui CG, Pan WS. Low molecular weight chitosan-coated liposomes for ocular drug delivery: in vitro and in vivo studies. Drug Deliv 19(1):28-35, 2012.
46. Liu J, Lawrence BD, Liu A, Schwab IR, Oliveira LA, Rosenblatt MI. Silk fibroin as a biomaterial substrate for corneal epithelial cell sheet generation. Invest Ophthalmol Vis Sci 53(7):4130-4138, 2012.
47. Low SP, Voelcker NH, Canham LT, Williams KA. The biocompatibility of porous silicon in tissues of the eye. Biomaterials 30(15):2873-2880, 2009.
48. Low SP, Williams KA, Canham LT, Voelcker NH. Evaluation of mammalian cell adhesion on surface-modified porous silicon. Biomaterials 27(26):4538-4546, 2006.
49. Majo F, Rochat A, Nicolas M, Jaoudé GA, Barrandon Y. Oligopotent stem cells are distributed throughout the mammalian ocular surface. Nature 456(7219):250-254, 2008.
50. McAlister JC, Joyce NC, Harris DL, Ali RR, Larkin DF. Induction of replication in human corneal endothelial cells by E2F2 transcription factor cDNA transfer. Invest Ophthalmol Vis Sci 46(10):3597-3603, 2005.
51. Menzel-Severing J, Kruse FE, Schlötzer-Schrehardt U. Stem cell-based therapy for corneal epithelial reconstruction: present and future. Can J Ophthalmol 48(1):13-21, 2013.
52. Mills RA, Klebe S, Coster DJ, Williams KA. Comparative outcomes of penetrating and component endothelial cell corneal allografts in outbred sheep. Cell Transplant, epub ahead of print, Dec. 4, 2012.
53. Morand K, Bartoletti AC, Bochot A, Barratt G, Brandely ML, Chast F. Liposomal amphotericin B eye drops to treat fungal keratitis: physico-chemical and formulation stability. Int J Pharm 344(1-2):150-153, 2007.
54. Ordonez P, Di Girolamo N. Limbal epithelial stem cells: role of the niche microenvironment. Stem Cells 30(2):100-107, 2012.
55. Ortega I, Ryan AJ, Deshpande P, MacNeil S, Claeyssens F. Combined microfabrication and electrospinning to produce 3-D architectures for corneal repair. Acta Biomater 9(3):5511-5520, 2013.
56. Parker DG, Brereton HM, Klebe S, Coster DJ, Williams KA. A steroid-inducible promoter for the cornea. Br J Ophthalmol 93(9):1255-1259, 2009.
57. Peng YJ, Kau YC, Wen CW, Liu KS, Liu SJ. Solvent-free biodegradable scleral plugs providing sustained release of vancomycin, amikacin, and dexamethasone - an in vivo study. J Biomed Mater Res A 94(2):426-432, 2010.
58. Petsoglou C, Balaggan KS, Dart JK, Bunce C, Xing W, Ali RR, Tuft SJ. Subconjunctival bevacizumab induces regression of corneal neovascularisation: a pilot randomised placebo-controlled double-masked trial. Br J Ophthalmol 97:28-32, 2013.
59. Pisanti S, Picardi P, Prota L, Proto MC, Laezza C, Mcguire PG, Morbidelli L, Gazzerro P, Ziche M, Das A, Bifulco M. Genetic and pharmacologic inactivation of cannabinoid CB1 receptor inhibits angiogenesis. Blood 117(20):5541-5550, 2011.
60. Price MO, Gorovoy M, Price FW Jr, Benetz BA, Menegay HJ, Lass JH. Descemet's stripping automated endothelial keratoplasty: three-year graft and endothelial cell survival compared with penetrating keratoplasty. Ophthalmology 120(2):246-251, 2013.
61. Ronkko S, Kaarniranta K, Kalesnykas G, Uusitalo H. Biocompatibility of different poly(lactide-coglycolide) polymers implanted into the subconjunctival space in rats. Ophthalmic Res 46(2):55-65, 2011.
62. Saika S. Yin and yang in cytokine regulation of corneal wound healing: roles of TNF-alpha. Cornea 26(9 Suppl 1):S70-S74, 2007.
63. Sandri G, Bonferoni MC, Gokce EH, Ferrari F, Rossi S, Patrini M, Caramella C. Chitosan-associated SLN: in vitro and ex vivo characterization of cyclosporine A loaded ophthalmic systems. J Microencapsul 27(8):735-746, 2010.
64. Sharma S, Mohanty S, Gupta D, Jassal M, Agrawal AK, Tandon R. Cellular response of limbal epithelial cells on electrospun poly-ε-caprolactone nanofibrous scaffolds for ocular surface bioengineering: a preliminary in vitro study. Mol Vis 17:2898-2910, 2011.
65. Snell RS, Lemp MA. Clinical Anatomy of the Eye, 2nd Edition. Blackwell Science, Hoboken, New Jersey, USA, 1998.
66. Stevenson W, Cheng SF, Dastjerdi MH, Ferrari G, Dana R. Corneal neovascularization and the utility of topical VEGF inhibition: ranibizumab (Lucentis) vs bevacizumab (Avastin). Ocul Surf 10(2):67-83, 2012.
67. Sun TT, Tseng SC, Lavker RM. Location of corneal epithelial stem cells. Nature 463(7284):E10-E11; discussion E11, 2010.
68. Tan A, Tan DT, Tan XW, Mehta JS. Osteo-odonto keratoprosthesis: systematic review of surgical outcomes and complication rates. Ocul Surf 10(1):15-25, 2012.
69. Tan DT, Dart JK, Holland EJ, Kinoshita S. Corneal transplantation. Lancet 379(9827):1749-1761, 2012.
70. Tang XL, Sun JF, Wang XY, Du LL, Liu P. Blocking neuropilin-2 enhances corneal allograft survival by selectively inhibiting lymphangiogenesis on vascularized beds. Mol Vis 16:2354-2361, 2010.
71. Thiel MA, Coster DJ, Standfield SD, Brereton HM, Mavrangelos C, Zola H, Taylor S, Yusim A, Williams KA. Penetration of engineered antibody fragments into the eye. Clin Exp Immunol 128(1):67-74, 2002.
72. Thiel MA, Wild A, Schmid MK, Job O, Bochmann F, Loukopoulos V, Alcantara W, Schmidt A, Lichtlen P, Escher D. Penetration of a topically administered anti-tumor necrosis factor alpha antibody fragment into the anterior chamber of the human eye. Ophthalmology, epub ahead of print, Mar. 12, 2013.
73. Tsai RJ, Li LM, Chen JK. Reconstruction of damaged corneas by transplantation of autologous limbal epithelial cells. N Engl J Med 343(2):86-93, 2000.
74. van Essen TH, Lin CC, Hussain AK, Maas S, Lai HJ, Linnartz H, van den Berg TJ, Salvatori DC, Luyten GP, Jager MJ. A fish scale-derived collagen matrix as artificial cornea in rats: properties and potential. Invest Ophthalmol Vis Sci, epub ahead of print, Apr. 11, 2013.
75. Whitcher JP, Srinivasan M, Upadhyay MP. Corneal blindness: a global perspective. Bull World Health Organ 79(3):214-221, 2001.
76. Williams KA, Coster DJ. Gene therapy for diseases of the cornea - a review. Clin Experiment Ophthalmol 38(2):93-103, 2010.
77. Williams KA, Coster DJ. The immunobiology of corneal transplantation. Transplantation 84(7):806-813, 2007.
78. Williams KA, Lowe M, Bartlett C, Kelly TL, Coster DJ, All Contributors. Risk factors for human corneal graft failure within the Australian corneal graft registry. Transplantation 86(12):1720-1724, 2008.
79. Wright B, Mi S, Connon CJ. Towards the use of hydrogels in the treatment of limbal stem cell deficiency. Drug Discov Today 2013 18(1-2):79-86, 2013.
80. Yao WJ, Sun KX, Liu Y, Liang N, Mu HJ, Yao C, Liang RC, Wang AP. Effect of poly(amidoamine) dendrimers on corneal penetration of puerarin. Biol Pharm Bull 33(8):1371-1377, 2010.
81. Zagon IS, Sassani JW, Malefyt KJ, Mclaughlin PJ. Regulation of corneal repair by particle-mediated gene transfer of opioid growth factor receptor complementary DNA. Arch Ophthalmol 124(11):1620-1624, 2006.
82. Zagon IS, Sassani JW, Verderame MF, Mclaughlin PJ. Particle-mediated gene transfer of opioid growth factor receptor cDNA regulates cell proliferation of the corneal epithelium. Cornea 24(5):614-619, 2005.
83. Zhu X, Su M, Tang S, Wang L, Liang X, Meng F, Hong Y, Xu Z. Synthesis of thiolated chitosan and preparation nanoparticles with sodium alginate for ocular drug delivery. Mol Vis 18:1973-1982, 2012.
84. Zuo L, Fan Y, Wang F, Gu Q, Xu X. A siRNA targeting vascular endothelial growth factor-A inhibiting experimental corneal neovascularization. Curr Eye Res 35(5):375-384, 2010.